Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - December 2024

Click here to read the articles and download the PDF

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Going Inside the Gross-to-Net Bubble and Its Nuances

A crash course on the bubble itself, including therapeutic areas most affected.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Pharma Pulse 5/3/24: Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients, Thermo Fisher Scientific Launches New Testing Service & more

May 03, 2024

The latest news for pharma industry insiders.

A Look at the Effects of the Inflation Reduction Act

May 02, 2024

Study explores how the Inflation Reduction Act’s Drug Price Negotiation Program and its maximum fair prices impact incentives for investments in post-approval activity.

Kenco, QPharma Collaborate on Improving Supply Chain Challenges

May 02, 2024

The partnership revolves around augmenting regulatory compliance, along with drug sampling distribution and compliance.

Pharma Pulse 5/2/24: The Impact of IRA on Drug Prices and Patient Access, Early Communication Crucial for Successful Drug Launch & more

May 02, 2024

The latest news for pharma industry insiders.

Sygnature Discovery Given Award for Sustainability

May 01, 2024

The CRO earned a Bronze rating for criteria based on environmental, social, and ethical performance.

Air Freight Demand Continues Its Climb in March

May 01, 2024

IATA data points to a fourth consecutive month of double-digit, year-on-year growth.

Pharma Pulse 5/1/24: Tailoring AI Regulation in Healthcare, OpenAI and Microsoft Sued Over AI & more

May 01, 2024

The latest news for pharma industry insiders.

ONO Pharmaceutical Solidifies $2.4 Billion Acquisition of Deciphera

April 30, 2024

The merger exponentially grows ONO’s oncology pipeline.

Merck KGaA Financially Commits $322 Million Toward Research Center

April 30, 2024

The complex will research solutions for manufacturing antibodies, mRNA applications, and more.

Pharma Pulse 4/30/24: Advocating For Weight Loss Medication, AI Start-Ups Face Rough Financial Reality Check & more

April 30, 2024

The latest news for pharma industry insiders.